Most Recent
A class action by frustrated buyers over the $85 million sale of a Sydney development has failed to prevent the sale of lots, with a judge finding the class action's claims lack evidence.
Samsung Bioepis can't get indemnity costs from Janssen Biotech after it surrendered patents for Crohn’s disease drug Stelara and filed a fresh case based on new patents for the drug.
Former senator Rex Patrick has defeated the Attorney General's appeal of a ruling which clarified that a loophole cannot be used to avoid Freedom of Information requests when a minister leaves office.
Dentons Australia chair and CEO Doug Stipanicev has hit back at claims made in a lawsuit by a former partner over an article he shared that spewed anti-vaccine conspiracy theories.
Vanguard Investments has been ordered to pay a penalty of almost $13 million for misleading the public about its $1 billion “ethically conscious” hedge fund.
Victorian Liberal leader John Pesutto has admitted to sharing with ex-state premier Jeff Kennett aspects of settlement discussions with ousted party member Moira Deeming.
Dentons is facing a lawsuit by a former partner who alleges the law firm's Australian chair emailed him a conspiracy-laden anti-vaccine pamphlet.
The director of collapsed investment firm Linchpin Capital has lost his challenge to a $150,000 penalty, with an appeals court dismissing his arguments as “carping criticism”.
Shareholders in lending platform Marketlend can bring a derivative suit against its directors for allegedly misusing company funds, including spending $1.3 million on barrister chambers fees.
The nephew of Clive Palmer and former director of Queensland Nickel has failed to reverse a decision rejecting his bid to dismiss contempt proceedings related to the company’s collapse.